DEF 14A Filing

Company

TherapeuticsMD, Inc.

Filed

December 7, 2007

Period of Report

December 21, 2007

Accession Number

0001214659-07-002622

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →